bifunctional anti-KDR/anti-flt4 antibody (Imclone)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namebifunctional anti-KDR/anti-flt4 antibody (Imclone)
Drug Alias NameVEGF-1/VEGF-2 diabody (Imclone)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionVascular endothelial growth factor receptor 3 antagonistsVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 3Vascular endothelial growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImclone Systems
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImclone Systems
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A